AFP and hepatocellular carcinoma: Further stratified analysis of high-risk recurrence factors showed that patients with high AFP levels benefited significantly from postoperative TACE therapy, suggesting that high AFP levels are not only a marker of poor prognosis of HCC, but also a marker of priority for TACE therapy.